Medical Sources
Every claim Pureami Tea Company makes is grounded in published, peer-reviewed medical literature. Below are the sources — all available free at PubMed.com.
Our Commitment to Transparency
The three names — Myricetin, DiHydroMyricetin, and Ampelopsin — all refer to the same flavonol. Search any of them on PubMed.com and you will find a substantial body of evidence. Qing Yun Moyeam produces this compound at 30–40% by plant weight, versus 3–6% for ordinary grades.
We do not cherry-pick studies. We have never made a claim not supported by the published literature. All citations below link directly to their source on PubMed or the original journal.
Showing all teas · er-breast-cancer. Clear filter
Qing Yun Moyeam
Ampelopsis Grossedentata — Myricetin / DiHydroMyricetin / Ampelopsin
ER+ Breast Cancer
PubMed
Myricetin inhibited a key enzyme that drives the growth of estrogen receptor-positive (ER+) breast cancer cells, pointing to its potential as a natural chemopreventive agent.
Eagle Tea
Litsea coreana — Hawk tea
ER+ Breast Cancer
PubMed
Kaempferol inhibited the growth of ER+ breast cancer cells by cutting off their glucose supply — effectively starving the tumor cells of the energy they need to proliferate.
Disclaimer: The research cited above is provided for educational purposes only and reflects the findings of independent researchers. Pureami Tea Company does not claim that Moyeam diagnoses, treats, cures, or prevents any disease. These statements have not been evaluated by the FDA. Consult your healthcare provider before making any changes to your diet or supplement regimen.